ABP – abpro holdings, inc (US:NASDAQ)
Stock Stats
News
Abpro (NASDAQ:ABP) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Abpro Holdings Announces Submission of an IND Application to Initiate a Phase 1 Clinical Trial of T cell engager ABP-102/CT-P72 for HER2-positive Cancers [Yahoo! Finance]
Abpro Holdings Announces Submission of an IND Application to Initiate a Phase 1 Clinical Trial of T cell engager ABP-102/CT-P72 for HER2-positive Cancers
Abpro Granted Nasdaq Listing Extension to Pursue Compliance and Strategic Objectives
Abpro (NASDAQ:ABP) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Form 8-K Abpro Holdings, Inc. For: Dec 15
Form 8-K Abpro Holdings, Inc. For: Dec 09
Form EFFECT Abpro Holdings, Inc.
Form S-1/A Abpro Holdings, Inc.
Form 424B3 Abpro Holdings, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.